drugset / Trial / NCT00704600
Nelfinavir, a Phase I/Phase II Rectal Cancer Study
NaSingle-groupOpen-labelTreatment
Summary
The aim is to study safety and activity of nelfinavir , added to standard chemoradiotherapy in patients with locally advanced rectal cancer. Furthermore analysis of the effect of nelfinavir combined with chemoradiation on tumour tissue will be studied
Timeline
- Start
- 2008-09
- Primary completion
- 2010-09
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelfinavir | Other / unclassified | 750 mg | Oral |
| Subject | Nelfinavir | Other / unclassified | 1250 mg | Oral |